Skip to main content
Clinical Trials/DRKS00017543
DRKS00017543Completed未知

Comparing the effectiveness of the treatment of hidradenitis suppurativa (acne inversa) with the combination of LAight® therapy with guideline-based drug therapy in relation to guideline-based drug therapy alone - RELIEVE

niversitätsmedizin der Johannes Gutenberg-Universität Mainz0 sites88 target enrollmentStarted: June 25, 2019Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
88

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomized controlled study
Masking
Blinded (masking used)

Eligibility Criteria

Ages
18 Years to one (—)
Sex
All

Inclusion Criteria

  • 1. Age = 18;
  • 2. Disease severity: Hurley stage 1 or Hurley stage 2;
  • 3. At least one affected area typical for HS (axillary, inguinal, gluteal, mammary);
  • 4. At least 3 inflammatory nodules or abscesses;
  • 5. The mental ability to understand the patient information and follow the study procedure.

Exclusion Criteria

  • 1. Disease severity: Hurley stage 3;
  • 2. Medical guideline therapy not possible;
  • 3. Other disease that leads to systemic Inflammation;
  • 4. Therapy with antibiotics or retinoids within the last 2 weeks;
  • 5. Pre-treatment with the LAight®-therapy;
  • 6. Contraindications LAight®-therapy;
  • a) Pregnancy;
  • b) Epilepsy;
  • c) Electronically controlled implants (e.g. Pacemaker, cardiac stimulator)
  • d) Extreme photosensitivity (also of a medicinal nature);
  • e) Melanoma or skin Cancer;
  • f) Contagious skin diseases;
  • g) Tattoos, piercing, permanent make-up or branding on the body parts to be treated;
  • h) Injections (within the last 6 months) on the body parts to be treated (e.g. Botox or Hyaluron);
  • i) Implants at a radius of 10 cm to the body parts to be treated

Investigators

Similar Trials

Comparing the effectiveness of the... | Clinical Trial